BioNTech SE

BNTX chart

BioNTech SE news

• UBS keeps USD 135 target for BioNTech stock as results near

  ad-hoc-news.de · Oct 27, 5:43 PM EDT

• The $1.5 Billion Question Facing Tempus AI Ahead of Nov. 2 Earnings

  247wallst.com · Oct 27, 9:28 AM EDT

• BioNTech SE : JP Morgan gives a Neutral rating

  marketscreener.com · Oct 27, 8:48 AM EDT

• BioNTech SE : UBS reiterates its Buy rating

  marketscreener.com · Oct 26, 12:06 PM EDT

• BioNTech (BNTX) Stock May Be Above Fair Value After Lung Cancer Data

  Simply Wall Street · Oct 26, 10:49 AM EDT

• BioNTech SE (BNTX) stock price, news, quote and history

  Yahoo Finance Singapore · Oct 26, 9:26 AM EDT

• Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady

  247wallst.com · Oct 26, 9:14 AM EDT

• BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer

  Yahoo Finance · Oct 26, 5:00 AM EDT

• BioNTech's drug modestly extended time without cancer progression vs. chemo. A few had severe or fatal lung disease.

  Stock Titan · Oct 26, 5:00 AM EDT

• BioNTech SE (BNTX) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Oct 25, 9:12 PM EDT

• BioNTech (BNTX) Expanded Its Oncology Pipeline, Is It Still 25% Below Fair Value?

  Yahoo Finance · Oct 25, 10:16 AM EDT

• BioNTech (BNTX) Reworks Phase 3 Breast Cancer Trial Around New Combination Approach

  Yahoo Finance · Oct 25, 8:14 AM EDT

BioNTech SE key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-10-26
• 6-K6-K2026-10-26
• 6-K6-K2026-10-22
• 6-K6-K2026-10-19
• 6-K6-K2026-10-13
• 6-K6-K2026-09-18
• 6-K6-K2026-09-14
• 6-K6-K2026-08-28
• 6-K6-K2026-08-27
• 6-K6-K2026-08-20
• 6-K6-K2026-08-04
• 6-K6-K2026-08-04

About BioNTech SE

Ticker

BNTX (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

Mainz, Germany

Incorporated in

Germany

Fiscal year end

December 31

SEC CIK

1776985

Frequently asked questions